Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis

Free Radical Biology and Medicine

Volumn 52, Issue 1, 2012, Pages 59-69

  Rolo, Anabela P ^a,b   Teodoro, João S ^a,c   Palmeira, Carlos M ^a,c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF AVEIRO   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Cytokines; Fatty acids; Free radicals; Inflammation; Mitochondria; NASH; Oxidation; Oxidative stress

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOKINE; FATTY ACID; GLUTATHIONE; NICOTINAMIDE ADENINE DINUCLEOTIDE; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL;

CYTOKINE PRODUCTION; END STAGE LIVER DISEASE; ENERGY METABOLISM; FATTY ACID OXIDATION; INFLAMMATION; LIPOGENESIS; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY CHAIN; REVIEW;

ANIMALS; CYTOKINES; DNA DAMAGE; FATTY ACIDS, NONESTERIFIED; FATTY LIVER; HEPATOCYTES; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIPID PEROXIDATION; MICE; MITOCHONDRIA; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEOLYSIS; RATS; REACTIVE OXYGEN SPECIES; TRIGLYCERIDES;

EID: 84655169624     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2011.10.003     Document Type: Review

References (220)

1. B. Neuschwander-Tetri, and S. Caldwell Nonalcoholic steatohepatitis: summary of an AASLD single topic conference Hepatology 37 2003 1202 1219 (Pubitemid 36538699)
2. J. Ludwig, T.R. Viggiano, D.B. McGill, and B.J. Oh Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease Mayo Clin. Proc. 55 1980 434 438 (Pubitemid 10057164)
3. A.M. Diehl Nonalcoholic steatohepatitis Semin. Liver Dis. 19 1999 221 229
4. D. Pessayre, A. Mansouri, and B. Fromenty Mitochondrial dysfunction in steatohepatitis Am. J. Physiol. Gastrointest. Liver Physiol. 282 2002 G193 G199
5. S.H. Caldwell, and D.M. Crespo The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease J. Hepatol. 40 2004 578 584 (Pubitemid 38367778)
6. J.M. Hui, J.G. Kench, S. Chitturi, A. Sud, G.C. Farrell, K. Byth, P. Hall, M. Khan, and J. George Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C Hepatology 38 2003 420 427 (Pubitemid 36919863)
7. G. Bedogni, L. Miglioli, F. Masutti, C. Tiribelli, G. Marchesini, and S. Bellentani Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos Nutrition and Liver Study Hepatology 42 2005 44 52 (Pubitemid 40911310)
8. J.D. Browning, L.S. Szczepaniak, R. Dobbins, P. Nuremberg, J.D. Horton, J.C. Cohen, S.M. Grundy, and H.H. Hobbs Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity Hepatology 40 2004 1387 1395 (Pubitemid 39657013)
9. H. Lu, L. Zeng, B. Liang, X. Shu, and D. Xie High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease Arch. Med. Res. 40 2009 571 575
10. B. Fromenty, and D. Pessayre Inhibition of mitochondrial β-oxidation as a mechanism of hepatotoxicity Pharmacol. Ther. 67 1995 101 154
11. A. Berson, V. De Beco, P. Lettéron, M.A. Robin, C. Moreau, J. El Kahwaji, N. Verthier, G. Feldmann, B. Fromenty, and D. Pessayre Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes Gastroenterology 114 1998 764 774 (Pubitemid 28160411)
12. G.C. Farrell Drugs and steatohepatitis Semin. Liver Dis. 22 2002 185 194 (Pubitemid 34496471)
13. H. Cortez-Pinto, A. Baptista, M.E. Camilo, E.B. de Costa, A. Valente, and M.C. de Moura Tamoxifen-associated steatohepatitis-report of three cases J. Hepatol. 23 1995 95 97
14. S. Bruno, P. Maisonneuve, P. Castellana, N. Rotmensz, S. Rossi, M. Maggioni, M. Persico, A. Colombo, F. Monasterolo, D. Casadei-Giunchi, F. Desiderio, T. Stroffolini, V. Sacchini, A. Decensi, and U. Veronesi Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial Br. Med. J. 330 2005 932
15. B. Hu, and S.W. French 20,30-Dideoxyinosine-induced Mallory bodies in patients with HIV Am. J. Clin. Pathol. 108 1997 280 283 (Pubitemid 27371645)
16. M.E. Coglan, P. Sommadossi, N.C. Jhala, W.J. Many, M.S. Saag, and V.A. Johnson Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: a report of 12 cases Clin. Infect. Dis. 33 2001 1914 1921 (Pubitemid 33105134)
17. J.P. Van Huyen, A. Landau, C. Piketty, M.F. Belair, D. Batisse, G. Gonzalez-Canali, L. Weiss, R. Jian, M.D. Kazatchkine, and P. Bruneval Toxic effects of nucleoside reverse transcriptase inhibitors on the liver: value of electron microscopy analysis for the diagnosis of mitochondrial cytopathy Am. J. Clin. Pathol. 119 2003 546 555 (Pubitemid 37046406)
18. B. Fromenty, M.A. Robin, A. Igoudjii, A. Mansouri, and D. Pessayre The ins and outs of mitochondrial dysfunction in NASH Diabetes Metab. 30 2004 121 138 (Pubitemid 38715168)
19. K. Begriche, A. Igoudjil, D. Pessayre, and B. Fromenty Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it Mitochondrion 6 2006 1 28
20. G. Robertson, I. Leclercq, and G.C. Farrell Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress Am. J. Physiol. Gastrointest. Liver Physiol. 281 2001 G1135 G1139
21. J.M. Matés, J.A. Segura, F.J. Alonso, and J. Márquez Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis Arch. Toxicol. 82 2008 273 299
22. R. Mittler, S. Vanderauwera, N. Suzuki, G. Miller, V.B. Tognetti, K. Vandepoele, M. Gollery, V. Skulachev, and F. Van Breusegem ROS signaling: the new wave? Trends Plant Sci. 16 2011 300 309
23. B. D'Autréaux, and M.B. Toledano ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis Nat. Rev. Mol. Cell Biol. 8 2007 813 824 (Pubitemid 47462134)
24. •- Free Radic. Biol. Med. 26 1999 777 778 (Pubitemid 29146282)
25. J.S. Beckman, and W.H. Koppenol Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly Am. J. Physiol. 271 1996 C1424 C1437
26. R. Radi, A. Cassina, R. Hodara, C. Quijano, and L. Castro Peroxynitrite reactions and formation in mitochondria Free Radic. Biol. Med. 33 2002 1451 1464 (Pubitemid 35351588)
27. B. Halliwell, and J.M.C. Gutteridge Free Radicals in Biology and Medicine 1999 Oxford Univ. Press Oxford
28. H. Østerbauer, R.J. Schaur, and H. Zollner Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes Free Radic. Biol. Med. 11 1991 81 128 (Pubitemid 121003917)
29. H.W. Gardner Oxygen radical chemistry of polyunsaturated fatty acids Free Radic. Biol. Med. 7 1989 65 86 (Pubitemid 19165157)
30. B.A. Wagner, G.R. Buettner, and C.P. Burns Free radical-mediated lipid peroxidation in cells: oxidizability is a function of cell lipid bis-allylic hydrogen content Biochemistry 33 1994 4449 4453 (Pubitemid 24145090)
31. R.C. Zangar, D.R. Davydov, and S. Verma Mechanisms that regulate production of reactive oxygen species by cytochrome P450 Toxicol. Appl. Pharmacol. 199 2004 316 331 (Pubitemid 39208731)
32. A.A. Caro, and A.I. Cederbaum Role of cytochrome P450 in phospholipase A2- and arachidonic acid-mediated cytotoxicity Free Radic. Biol. Med. 40 2006 364 375 (Pubitemid 43139672)
33. 2 by peroxisomes Free Radic. Biol. Med. 42 2007 1119 1129 (Pubitemid 46357671)
34. N.A. Bonekamp, A. Völkl, H.D. Fahimi, and M. Schrader Reactive oxygen species and peroxisomes: struggling for balance Biofactors 35 2009 346 355
35. M.P. Murphy How mitochondria produce reactive oxygen species Biochem. J. 417 2009 1 13
36. M.D. Brand The sites and topology of mitochondrial superoxide production Exp. Gerontol. 45 2010 466 472
37. J.F. Turrens Mitochondrial formation of reactive oxygen species J. Physiol. 552 2003 335 344 (Pubitemid 37321833)
38. A.A. Starkov, G. Fiskum, C. Chinopoulos, B.J. Lorenzo, S.E. Browne, M.S. Patel, and M.F. Beal Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species J. Neurosci. 24 2004 7779 7788 (Pubitemid 39215681)
39. E. Migliaccio, M. Giorgio, and P.G. Pelicci Apoptosis and aging: role of p66Shc redox protein Antioxid. Redox Signal. 8 2006 600 608 (Pubitemid 43741328)
40. A.Y. Andreyev, Y.E. Kushnareva, and A.A. Starkov Mitochondrial metabolism of reactive oxygen species Biochemistry (Moscow) 70 2005 200 214 (Pubitemid 40512329)
41. V.P. Skulachev Role of uncoupled and non-coupled oxidations in maintenance of safely low levels of oxygen and its one-electron reductants Q. Rev. Biophys. 29 1996 169 202 (Pubitemid 26280789)
42. A.J. Lambert, and M.D. Brand Inhibitors of the quinone binding site allow rapid superoxide production from mitochondrial NADH:ubiquinone oxidoreductase (complex I) J. Biol. Chem. 279 2004 39414 39420 (Pubitemid 39258206)
43. V.P. Skulachev Uncoupling: new approaches to an old problem of bioenergetics Biochim. Biophys. Acta 1363 1998 100 124 (Pubitemid 28129344)
44. S.S. Korshunov, V.P. Skulachev, and A.A. Starkov High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria FEBS Lett. 416 1997 15 18 (Pubitemid 27470791)
45. M. Okuda, H.C. Lee, C. Kumar, and B. Chance Comparison of the effect of a mitochondrial uncoupler, 2,4-dinitrophenol and adrenaline on oxygen radical production in the isolated perfused rat liver Acta Physiol. Scand. 145 1992 159 168
46. M.P. Murphy, K.S. Echtay, F.H. Blaikie, J. Asin-Cayuela, H.M. Cocheme, K. Green, J.A. Buckingham, E.R. Taylor, F. Hurrell, G. Hughes, S. Miwa, C.E. Cooper, D.A. Svistunenko, R.A. Smith, and M.D. Brand Superoxide activates uncoupling proteins by generating carbon-centered radicals and initiating lipid peroxidation: studies using a mitochondria-targeted spin trap derived from alpha-phenyl-N-tert-butylnitrone J. Biol. Chem. 278 2003 48534 48545 (Pubitemid 41079491)
47. A.S. Divakaruni, and M.D. Brand The regulation and physiology of mitochondrial proton leak Physiology 26 2011 192 205
48. F.Q. Schafer, and G.R. Buettner Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple Free Radic. Biol. Med. 30 2001 1191 1212 (Pubitemid 32463931)
49. D. Haouzi, M. Lekehal, M. Tinel, N. Vadrot, L. Caussanel, P. Letteéron, A. Moreau, G. Feldmann, D. Fau, and D. Pessayre Prolonged, but not acute, glutathione depletion promotes Fas-mediated mitochondrial permeability transition and apoptosis in mice Hepatology 33 2001 1181 1188 (Pubitemid 32378218)
50. J.C. Fernandez-Checa, and N. Kaplowitz Hepatic mitochondrial glutathione: transport and role in disease and toxicity Toxicol. Appl. Pharmacol. 204 2005 263 273 (Pubitemid 40545231)
51. M. Salvi, V. Battaglia, A.M. Brunati, N. La Rocca, E. Tibaldi, P. Pietrangeli, L. Marcocci, B. Mondovì, C.A. Rossi, and A. Toninello Catalase takes part in rat liver mitochondria oxidative stress defense J. Biol. Chem. 282 2007 24407-22415
52. L.I. Rachek, L.V. Yuzefovych, S.P. Ledoux, N.L. Julie, and G.L. Wilson Troglitazone, but not rosiglitazone, damages mitochondrial DNA and induces mitochondrial dysfunction and cell death in human hepatocytes Toxicol. Appl. Pharmacol. 240 2009 348 354
53. C. Ricci, V. Pastukh, J. Leonard, J. Turrens, G. Wilson, D. Schaffer, and S.W. Schaffer Mitochondrial DNA damage triggers mitochondrial-superoxide generation and apoptosis Am. J. Physiol. Cell Physiol. 294 2008 C413 C422
54. E.A. Schon, E. Bonilla, and S. DiMauro Mitochondrial DNA mutations and pathogenesis J. Bioenerg. Biomembr. 29 1997 131 149 (Pubitemid 27314972)
55. D.F. Bogenhagen Repair of mtDNA in vertebrates Am. J. Hum. Genet. 64 1999 1276 1281
56. D.C. Wallace, and W. Fan Energetics, epigenetics, mitochondrial genetics Mitochondrion 10 2010 12 31
57. C.P. Day, and O.F. James Steatohepatitis: a tale of two hits? Gastroenterology 114 1998 842 845
58. J.M. Lavoie, and M.S. Gauthier Regulation of fat metabolism in the liver: link to non-alcoholic hepatic steatosis and impact of physical exercise Cell. Mol. Life Sci. 63 2006 1393 1409
59. P. Tessari, A. Coracina, A. Cosma, and A. Tiengo Hepatic lipid metabolism and non-alcoholic fatty liver disease Nutr. Metab. Cardiovasc. Dis. 19 2009 291 302
60. M. Parola, and F. Marra Adipokines and redox signaling: impact on fatty liver disease Antioxid. Redox Signal. 15 2011 461 483
61. C.Z. Larter, S. Chitturi, D. Heydet, and G.C. Farrell A fresh look at NASH pathogenesis. Part 1. The metabolic movers J. Gastroenterol. Hepatol. 25 2010 672 690
62. S.A. Polyzos, J. Kountouras, and C. Zavos Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines Curr. Mol. Med. 9 2009 299 314
63. J.M. Hui, A. Hodge, G.C. Farrell, J.G. Kench, A. Kriketos, and J. George Beyond insulin resistance in NASH: TNF-α or adiponectin? Hepatology 40 2004 46 54 (Pubitemid 38868922)
64. A.J. Sanyal, C. Campbell-Sargent, F. Mirshahi, W.B. Rizzo, M.J. Contos, R.K. Sterling, V.A. Luketic, M.L. Shiffmann, and J.N. Clore Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities Gastroenterology 120 2001 1183 1192 (Pubitemid 32246672)
65. S. Chitturi, and G.C. Farrell Etiopathogenesis of nonalcoholic steatohepatitis Semin. Liver Dis. 21 2001 27 41 (Pubitemid 32240484)
66. S. Seki, T. Kitada, T. Yamada, H. Sakaguchi, K. Nakatani, and K. Wakasa In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases J. Hepatol. 37 2002 56 62 (Pubitemid 34713055)
67. G. Marchesini, R. Marzocchi, F. Agostini, and E. Bugianesi Nonalcoholic fatty liver disease and the metabolic syndrome Curr. Opin. Lipidol. 16 2005 421e7
68. A.E. Feldstein, N.W. Werneburg, Z. Li, S.F. Bronk, and G.J. Gores Bax inhibition protects against free fatty acid-induced lysosomal permeabilization Am. J. Physiol. Gastrointest. Liver Physiol. 290 2006 G1339 G1346
69. Y. Wei, D. Wang, F. Topczewski, and M.J. Pagliassotti Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells Am. J. Physiol. Endocrinol. Metab. 291 2006 E275e81
70. D. Pessayre, and B. Fromenty NASH: a mitochondrial disease J. Hepatol. 42 2005 928 940 (Pubitemid 40693212)
71. H. Cortez-Pinto, J. Chatham, V.P. Chacko, C. Arnold, A. Rashid, and A.M. Diehl Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study JAMA 282 1999 1659 1664 (Pubitemid 29513973)
72. K. Hensley, K.A. Robinson, S.P. Gabbita, S. Salsman, and R.A. Floyd Reactive oxygen species, cell signaling, and cell injury Free Radic. Biol. Med. 28 2000 1456 1462 (Pubitemid 30604227)
73. M. Pérez-Carreras, P. Del Hoyo, M.A. Martín, J.C. Rubio, A. Martín, G. Castellano, F. Colina, J. Arenas, and J.A. Solis-Herruzo Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis Hepatology 38 2003 999 1007 (Pubitemid 37221683)
74. S.H. Caldwell, R.H. Swerdlow, E.M. Khan, J.C. Iezzoni, E.E. Hespenheide, J.K. Parks, and W.D. Parker Jr. Mitochondrial abnormalities in non-alcoholic steatohepatitis J. Hepatol. 31 1999 430 434 (Pubitemid 29408724)
75. S. Seki, T. Kitada, T. Yamada, H. Sakaguchi, K. Nakatani, and K. Wakasa In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases J. Hepatol. 37 2002 56 62 (Pubitemid 34713055)
76. K.D. Chavin, S. Yang, H.Z. Lin, J. Chatham, V.P. Chacko, J.B. Hoek, E. Walajtys-Rode, A. Rashid, C.H. Chen, C.C. Huang, T.C. Wu, M.D. Lane, and A.M. Diehl Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion J. Biol. Chem. 274 1999 56925700
77. G. Serviddio, J. Sastre, F. Bellanti, J. Viña, G. Vendemiale, and E. Altomare Mitochondrial involvement in non-alcoholic steatohepatitis Mol. Aspects Med. 29 2008 22 35 (Pubitemid 351312221)
78. G. Vendemiale, I. Grattagliano, P. Caraceni, G. Caraccio, M. Domenicali, M. Dall'Agata, F. Trevisani, F. Guerrieri, M. Bernardi, and E. Altomare Mitochondrial oxidative injury and energy metabolism alteration in rat fatty liver: effect of the nutritional status Hepatology 33 2001 808 815 (Pubitemid 32246628)
79. J.S. Teodoro, A.P. Rolo, F.V. Duarte, A.M. Simões, and C.M. Palmeira Differential alterations in mitochondrial function induced by a choline-deficient diet: understanding fatty liver disease progression Mitochondrion 8 2008 367 376
80. J. Teodoro, A.P. Rolo, P.J. Oliveira, and C.M. Palmeira Decreased ANT content in Zucker fatty rats: relevance for altered hepatic mitochondrial bioenergetics in steatosis FEBS Lett. 580 2006 2153 2157
81. S. Nakamura, T. Takamura, N. Matsuzawa-Nagata, H. Takayama, H. Misu, H. Noda, S. Nabemoto, S. Kurita, T. Ota, H. Ando, K. Miyamoto, and S. Kaneko Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria J. Biol. Chem. 284 2009 14809 14818
82. H.J. Grav, K.J. Tronstad, O.A. Gudbrandsen, K. Berge, K.E. Fladmark, T.C. Martinsen, H. Waldum, H. Wergedahl, and R.K. Berge Changed energy state and increased mitochondrial beta-oxidation rate in liver of rats associated with lowered proton electrochemical potential and stimulated uncoupling protein 2 (UCP-2) expression: evidence for peroxisome proliferator-activated receptor-alpha independent induction of UCP-2 expression J. Biol. Chem. 278 2003 30525 30533 (Pubitemid 36994556)
83. A. Rashid, T.C. Wu, C.C. Huang, C.H. Chen, H.Z. Lin, S.Q. Yang, F.Y. Lee, and A.M. Diehl Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver Hepatology 29 1999 1131 1138 (Pubitemid 29168747)
84. L. Chen, Y. Zeng, H. Yang, T.D. Lee, S.W. French, F.J. Corrales, E.R. García-Trevijano, M.A. Avila, J.M. Mato, and S.C. Lu Impaired liver regeneration in mice lacking methionine adenosyltransferase 1A FASEB J. 18 2004 914 916
85. R.C. Scarpulla Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network Biochim. Biophys. Acta 1813 2011 1269 1278
86. A.P. Rolo, A.P. Gomes, and C.M. Palmeira Regulation of mitochondrial biogenesis in metabolic syndrome Curr. Drug Targets 12 2011 872 878
87. J. St-Pierre, S. Drori, M. Uldry, J.M. Silvaggi, J. Rhee, S. Jäger, C. Handschin, K. Zheng, J. Lin, W. Yang, D.K. Simon, R. Bachoo, and B.M. Spiegelman Suppression of reactive oxygen species and neurodegeneration by the PGC-I transcriptional coactivators Cell 127 2006 397 408 (Pubitemid 44572377)
88. M. Aharoni-Simon, M. Hann-Obercyger, S. Pen, Z. Madar, and O. Tirosh Fatty liver is associated with impaired activity of PPARγ-coactivator 1α (PGC1α) and mitochondrial biogenesis in mice Lab. Invest. 91 2011 1018 1028
89. S. Wang, A. Kamat, P. Pergola, A. Swamy, F. Tio, and K. Cusi Metabolic factors in the development of hepatic steatosis and altered mitochondrial gene expression in vivo Metabolism 60 2011 1090 1099
90. A. Nadal-Casellas, E. Amengual-Cladera, A.M. Proenza, I. Lladó, and M. Gianotti Long-term high-fat-diet feeding impairs mitochondrial biogenesis in liver of male and female rats Cell. Physiol. Biochem. 26 2010 291 302
91. V. Vartanian, B. Lowell, I.G. Minko, T.G. Wood, J.D. Ceci, S. George, S.W. Ballinger, C.L. Corless, A.K. McCullough, and R.S. Lloyd The metabolic syndrome resulting from a knockout of the NEIL1 DNA glycosylase Proc. Natl. Acad. Sci. U. S. A. 103 2006 1864 1869 (Pubitemid 43228784)
92. I. Gaou, M. Malliti, M.C. Guimont, P. Lettéron, C. Demeilliers, G. Peytavin, C. Degott, D. Pessayre, and B. Fromenty Effect of stavudine on mitochondrial genome and fatty acid oxidation in lean and obese mice J. Pharmacol. Exp. Ther. 297 2001 516 523 (Pubitemid 32377980)
93. R. Note, C. Maisonneuve, P. Lettéron, G. Peytavin, F. Djouadi, A. Igoudjil, M.C. Guimont, M. Biour, D. Pessayre, and B. Fromenty Mitochondrial and metabolic effects of nucleoside reverse-transcriptase inhibitors (NRTIs) in mice receiving one of five single- and three dual-NRTI treatments Antimicrob. Agents Chemother. 47 2003 3384 3392 (Pubitemid 37345694)
94. H. Jaeschke, G.J. Gores, A.I. Cederbaum, J.A. Hinson, D. Pessayre, and J.J. Lemasters Mechanisms of hepatotoxicity Toxicol. Sci. 65 2002 166 176 (Pubitemid 34121108)
95. K. Brinkman, H.J. ter Hofstede, D.M. Burger, J.A. Smeitink, and P.P. Koopmans Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway AIDS 12 1998 1735 1744 (Pubitemid 28454438)
96. C. Demeilliers, C. Maisonneuve, A. Grodet, A. Mansouri, R. Nguyen, M. Tinel, P. Lettéron, C. Degott, G. Feldmann, D. Pessayre, and B. Fromenty Impaired adaptive resynthesis and prolonged depletion of hepatic mitochondrial DNA after repeated alcohol binges in mice Gastroenterology 123 2002 1278 1290
97. A. Haque, M. Nishikawa, W. Qian, M. Mashimo, M. Hirose, S. Nishiguchi, and M. Inoue Lack of mitochondrial DNA enhances growth of hepatocellular carcinoma in vitro and in vivo Hepatol. Res. 36 2006 209 216 (Pubitemid 44575928)
98. F. Chiappini, A. Barrier, R. Saffroy, M.C. Domart, N. Dagues, D. Azoulay, M. Sebagh, B. Franc, S. Chevalier, B. Debuire, S. Dudoit, and A. Lemoine Exploration of global gene expression in human liver steatosis by high-density oligonucleotide microarray Lab. Invest. 86 2006 154 165 (Pubitemid 43117595)
99. H. Kawahara, M. Fukura, M. Tsuchishima, and S. Takase Mutation of mitochondrial DNA in livers from patients with alcoholic hepatitis and nonalcoholic steatohepatitis Alcohol. Clin. Exp. Res. 31 2007 S54 S60
100. S. Tamura, and I. Shimomura Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease J. Clin. Invest. 115 2005 1139 1142 (Pubitemid 40629030)
101. G. Musso, R. Gambino, and M. Cassader Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD) Prog. Lipid Res. 48 2009 1 26
102. E.S. Gorden Non-esterified fatty acids in blood of obese and lean subjects Am. J. Clin. Nutr. 8 1960 740 747
103. G. Marchesini, M. Brizi, G. Bianchi, S. Tomassetti, E. Bugianesi, M. Lenzi, A.J. McCullough, S. Natale, G. Forlani, and N. Melchionda Nonalcoholic fatty liver disease: a feature of the metabolic syndrome Diabetes 50 2001 1844 1850 (Pubitemid 33641605)
104. E. Fabbrini, B.S. Mohammed, F. Magkos, K.M. Korenblat, B.W. Patterson, and S. Klein Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease Gastroenterology 134 2008 424 431 (Pubitemid 351173050)
105. H.S. Sul, M.J. Latasa, Y. Moon, and K.H. Kim Regulation of the fatty acid synthase promoter by insulin J. Nutr. 130 2000 315S 320S (Pubitemid 30073737)
106. S.D. Clarke, and D.B. Jump Polyunsaturated fatty acid regulation of hepatic gene transcription Lipids 31 1996 S7 S11
107. J. Araya, R. Rodrigo, L.A. Videla, L. Thielemann, M. Orellana, P. Pettinelli, and J. Poniachik Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease Clin. Sci. (Lond.) 106 2004 635 643 (Pubitemid 38797577)
108. I. Shimomura, H. Shimano, B.S. Korn, Y. Bashmakov, and J.D. Horton Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver J. Biol. Chem. 273 1998 35299 35306 (Pubitemid 29028238)
109. R. Dentin, J.P. Pégorier, F. Benhamed, F. Foufelle, P. Ferré, V. Fauveau, M.A. Magnuson, J. Girard, and C. Postic Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression J. Biol. Chem. 279 2004 20314 20326 (Pubitemid 38623477)
110. K. Iizuka, R.K. Bruick, G. Liang, J.D. Horton, and K. Uyeda Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis Proc. Natl. Acad. Sci. U. S. A. 101 2004 7281 7286 (Pubitemid 38638024)
111. F. Foufelle, and P. Ferré New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c Biochem. J. 366 2002 377 391 (Pubitemid 35001682)
112. R. Dentin, J. Girard, and C. Postic Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver Biochimie 87 2005 81 86 (Pubitemid 40298769)
113. J.D. Browning, and J.D. Horton Molecular mediators of hepatic steatosis J. Clin. Invest. 114 2004 147 152
114. K. Takaishi, L. Duplomb, M. Wang, J. Li, and R.H. Unger Hepatic insig-1 or 2 overexpression reduces lipogenesis in obese Zucker diabetic rats and in fasted/refed normal rats Proc. Natl. Acad. Sci. U. S. A. 101 2004 7106 7111 (Pubitemid 38596450)
115. F. Diraison, P. Moulin, and M. Beylot Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease Diabetes Metab. 29 2003 5478 5485
116. M. Machado, and H. Cortez-Pinto Non-alcoholic fatty liver disease and insulin resistance Eur. J. Gastroenterol. Hepatol. 17 2005 823 826 (Pubitemid 41073319)
117. J.K. Reddy, and G.P. Mannaerts Peroxisomal lipid metabolism Annu. Rev. Nutr. 114 1994 343 370 (Pubitemid 24261842)
118. E.F. Johnson, C.N. Palmer, K.J. Griffin, and M.H. Hsu Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation FASEB J. 10 1996 1241 1248 (Pubitemid 26307509)
119. G.A. Cook, and M.S. Gamble Regulation of carnitine palmitoyltransferase by insulin results in decreased activity and decreased apparent Ki values for malonyl-CoA J. Biol. Chem. 262 1987 2050 2055
120. C. Baltzer, S.K. Tiefenböck, and C. Frei Mitochondria in response to nutrients and nutrient-sensitive pathways Mitochondrion 10 2010 589 597
121. J.D. McGarry, and D.W. Foster Regulation of hepatic fatty acid oxidation and ketone body production Annu. Rev. Biochem. 49 1980 395 420
122. J.C. Collins, I.H. Scheinberg, D.R. Giblin, and I. Sternlieb Hepatic peroxisomal abnormalities in abetalipoproteinemia Gastroenterology 97 1989 766 770 (Pubitemid 19205153)
123. N. Chalasani, J.C. Gorki, M.S. Asghar, A. Asghar, B. Foresman, S.D. Hall, and D.W. Crabb Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis Hepatology 37 2003 544 550 (Pubitemid 36258775)
124. 13C-octanoate breath test Am. J. Gastroenterol. 98 2003 2335 2365
125. L.J. Brady, P.S. Brady, D.R. Romsos, and C.L. Hoppel Elevated hepatic mitochondrial and peroxisomal oxidative capacities in fed and starved adult obese (ob/ob) mice Biochem. J. 231 1985 439 444 (Pubitemid 15244016)
126. J.D. McGarry, and D.W. Foster Importance of experimental conditions in evaluating the malonyl-CoA sensitivity of liver carnitine acyltransferase: studies with fed and starved rats Biochem. J. 200 1981 217 223 (Pubitemid 12218245)
127. Y. Lee, M.Y. Wang, T. Kakuma, Z.W. Wang, E. Babcock, K. McCorkle, M. Higa, Y.T. Zhou, and R.H. Unger Liporegulation in diet-induced obesity: the antisteatotic role of hyperleptinemia J. Biol. Chem. 276 2001 5629 5635
128. J.M. Paterson, N.M. Morton, C. Fievet, C.J. Kenyon, M.C. Holmes, B. Staels, J.R. Seckl, and J.J. Mullins Metabolic syndrome without obesity: hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice Proc. Natl. Acad. Sci. U. S. A. 101 2004 7088 7093 (Pubitemid 38596447)
129. B. Desvergne, and W. Wahli Peroxisome proliferator-activated receptors: nuclear control of metabolism Endocr. Rev. 20 1999 649 688 (Pubitemid 30650602)
130. M. Schreurs, F. Kuipers, and F.R. van der Leij Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome Obes. Rev. 11 2010 380 388
131. S. Kersten, J. Seydoux, J.M. Peters, F.J. Gonzalez, B. Desvergne, and W. Wahli Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting J. Clin. Invest. 103 1999 1489 1498
132. R.A. Memon, L.H. Tecott, K. Nonogaki, A. Beigneux, A.H. Moser, C. Grunfeld, and K.R. Feingold Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice Endocrinology 141 2000 4021 4031
133. T. Nakatani, N. Tsuboyama-Kasaoka, M. Takahashi, S. Miura, and O. Ezaki Mechanism for peroxisome proliferator-activated receptor-α activator-induced up-regulation of UCP-2 mRNA in rodent hepatocytes J. Biol. Chem. 277 2002 9562 9569 (Pubitemid 34953045)
134. R.B. Vega, J.M. Huss, and D.P. Kelly The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor α in the transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes Mol. Cell. Biol. 20 2000 1868 1876 (Pubitemid 30100203)
135. D.G. Hardie The AMP-activated protein kinase cascade: the key sensor of cellular energy status Endocrinology 144 2003 5179 5183 (Pubitemid 37476044)
136. W.W. Winder, B.F. Holmes, D.S. Rubink, E.B. Jensen, M. Chen, and J.O. Holloszy Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle J. Appl. Physiol. 88 2000 2219 2226 (Pubitemid 30453931)
137. K. Hensley, Y. Kotake, H. Sang, Q.N. Pye, G.L. Wallis, L.M. Kolker, T. Tabatabaie, C.A. Stewart, Y. Konishi, D. Nakae, and R.A. Floyd Dietary choline restriction causes complex I dysfunction and increased H2O2 generation in liver mitochondria Carcinogenesis 21 2000 983 989 (Pubitemid 30265144)
138. S. Yang, H. Zhu, Y. Li, H. Lin, K. Gabrielson, M.A. Trush, and A.M. Diehl Mitochondrial adaptations to obesity-related oxidant stress Arch. Biochem. Biophys. 378 2000 259 268 (Pubitemid 30397626)
139. N. Chalasani, M.A. Deeg, and D.W. Crab Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with non-alcoholic steatohepatitis Am. J. Gastroenterol. 99 2004 1497 1502 (Pubitemid 39193189)
140. Y. Sumida, T. Nakashima, T. Yoh, M. Furutani, A. Hirohama, Y. Kakisaka, Y. Nakajima, H. Ishikawa, H. Mitsuyoshi, T. Okanoue, K. Kashima, H. Nakamura, and J. Yodoi Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease J. Hepatol. 38 2003 32 38 (Pubitemid 36078521)
141. Z. Yesilova, H. Yaman, C. Oktenli, A. Ozcan, A. Uygun, E. Cakir, S.Y. Sanisoglu, A. Erdil, Y. Ates, M. Aslan, U. Musabak, M.K. Erbil, N. Karaeren, and K. Dagalp Systemic markers of lipid peroxidation and antioxidants in patients with non-alcoholic fatty liver disease Am. J. Gastroenterol. 100 2005 850 855 (Pubitemid 40592378)
142. P. Lettéron, B. Fromenty, B. Terris, C. Degott, and D. Pessayre Acute and chronic steatosis lead to in vivo lipid peroxidation in mice J. Hepatol. 24 1996 200 208 (Pubitemid 26059117)
143. I.A. Leclercq, G.C. Farrell, J. Field, D.R. Bell, F.J. Gonzalez, and G.R. Robertson CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine non-alcoholic steatohepatitis J. Clin. Invest. 105 2001 1067 1075 (Pubitemid 30217691)
144. S. Seki, T. Kitada, T. Yamada, H. Sakaguchi, K. Nakatani, and K. Wakasa In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases J. Hepatol. 37 2002 56 62 (Pubitemid 34713055)
145. K.J. Williams, and E.A. Fisher Oxidation, lipoproteins, and atherosclerosis: which is wrong, the antioxidants or the theory? Curr. Opin. Clin. Nutr. Metab. Care 8 2005 139 146
146. J.P. Infante, and V.A. Huszagh Secondary carnitine deficiency and impaired docosahexaenoic (22:6n-3) acid synthesis: a common denominator in the pathophysiology of diseases of oxidative phosphorylation and beta-oxidation FEBS Lett. 468 2002 1 5 (Pubitemid 30101670)
147. I.V. Turko, L. Li, K.S. Aulak, D.J. Stuehr, J.Y. Chang, and F. Murad
148. A.P. Rolo, and C.M. Palmeira Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress Toxicol. Appl. Pharmacol. 212 2006 167 178
149. C.S. Lieber CYP2E1: from ASH to NASH Hepatol. Res. 28 2004 1 11 (Pubitemid 38145781)
150. Q.M. Anstee, and R.D. Goldin Mouse models in non-alcoholic fatty liver disease and steatohepatitis research Int. J. Exp. Pathol. 87 2006 1 16
151. A. Moncion, N.T. Truong, A. Garrone, P. Beaune, R. Barouki, and I. De Waziers Identification of a 16-nucleotide sequence that mediates post-transcriptional regulation of rat CYP2E1 by insulin J. Biol. Chem. 277 2002 45904 45910 (Pubitemid 35417572)
152. A. Dey, and A.I. Cederbaum Induction of cytochrome P450 2E1 promotes liver injury in ob/ob mice Hepatology 45 2007 1355 1365 (Pubitemid 46918319)
153. J.H. Tonsgard, and G.S. Getz Effect of Reye's syndrome serum on isolated chinchilla liver mitochondria J. Clin. Invest. 76 1985 816 825 (Pubitemid 15023140)
154. I.A. Leclercq Antioxidant defence mechanisms: new players in the pathogenesis of non-alcoholic steatohepatitis? Clin. Sci. (Lond.) 106 2004 235 237 (Pubitemid 38365828)
155. L.A. Videla, R. Rodrigo, M. Orellana, V. Fernandez, G. Tapia, L. Quiñones, N. Varela, J. Contreras, R. Lazarte, A. Csendes, J. Rojas, F. Maluenda, P. Burdiles, J.C. Diaz, G. Smok, L. Thielemann, and J. Poniachik Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients Clin. Sci. (Lond.) 106 2004 261 268 (Pubitemid 38365832)
156. R. Sreekumar, B. Rosado, D. Rasmussen, and M. Charlton Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis Hepatology 38 2003 244 251 (Pubitemid 36775817)
157. L. Llacuna, A. Fernández, C.V. Montfort, N. Matías, L. Martínez, F. Caballero, A. Rimola, M. Elena, A. Morales, J.C. Fernández-Checa, and C. García-Ruiz Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury J. Hepatol. 54 2011 1002 1010
158. F. Caballero, A. Fernández, N. Matías, L. Martínez, R. Fucho, M. Elena, J. Caballeria, A. Morales, J.C. Fernández-Checa, and C. García-Ruiz Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-l-methionine and glutathione J. Biol. Chem. 285 2010 18528 18536
159. C. Garcia-Ruiz, and J.C. Fernandez-Checa Mitochondrial glutathione: hepatocellular survival-death switch J. Gastroenterol. Hepatol. 21 2006 S3 S6
160. M.L. Martínez-Chantar, E.R. García-Trevijano, M.U. Latasa, I. Pérez-Mato, M.M. Sánchez del Pino, F.J. Corrales, M.A. Avila, and J.M. Mato Importance of a deficiency in S-adenosyl-l-methionine synthesis in the pathogenesis of liver injury Am. J. Clin. Nutr. 76 2002 1177S 1182S (Pubitemid 35244698)
161. J.M. Mato, M.L. Martínez-Chantar, and S.C. Lu Methionine metabolism and liver disease Annu. Rev. Nutr. 28 2008 273 293
162. M.L. Martínez-Chantar, M. Vázquez-Chantada, U. Ariz, N. Martínez, M. Varela, Z. Luka, A. Capdevila, J. Rodríguez, A.M. Aransay, R. Matthiesen, H. Yang, D.F. Calvisi, M. Esteller, M. Fraga, S.C. Lu, C. Wagner, and J.M. Mato Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice Hepatology 47 2008 1191 1199 (Pubitemid 351547905)
163. M. Inoue, S. Tazuma, K. Kanno, H. Hyogo, K. Igarashi, and K. Chayama Bach1 gene ablation reduces steatohepatitis in mouse MCD diet model J. Clin. Biochem. Nutr. 48 2011 161 166
164. F. Marra, A. Gastaldelli, G. Svegliati Baroni, G. Tell, and C. Tiribelli Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis Trends Mol. Med. 14 2008 72 81
165. J.W. Haukeland, J.K. Dama, Z. Konopski, E.M. Løberg, T. Haaland, I. Goverud, P.A. Torjesen, K. Birkeland, K. Bjoro, and P. Aukrust Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2 J. Hepatol. 44 2006 1167 1174
166. A.G. Ruiz, F. Casafont, J. Crespo, A. Cayón, M. Mayorga, A. Estebanez, J.C. Fernadez-Escalante, and F. Pons-Romero Lipopolysaccharide- binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis Obes. Surg. 17 2007 1374 1380
167. J. Crespo, A. Cayón, P. Fernández-Gil, M. Hernández-Guerra, M. Mayorga, A. Domínguez-Díez, J.C. Fernández-Escalante, and F. Pons-Romero Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients Hepatology 34 2001 1158 1163 (Pubitemid 33096588)
168. A. Wieckowska, B.G. Papouchado, Z. Li, R. Lopez, N.N. Zein, and A.E. Feldstein Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis Am. J. Gastroenterol. 103 2008 1372 1379 (Pubitemid 351813900)
169. C. Carter-Kent, N.N. Zein, and A.E. Feldstein Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment Am. J. Gastroenterol. 103 2008 1036 1042 (Pubitemid 351501089)
170. K. Schulze-Osthoff, A.C. Bakker, B. Vanhaesebroeck, R. Beyaert, W.A. Jacob, and W. Fiers Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions: evidence for the involvement of mitochondrial radical generation J. Biol. Chem. 267 1992 5317 5323
171. H. Nagai, K. Matsumaru, G. Feng, and N. Kaplowitz Reduced glutathione depletion causes necrosis and sensitization to tumor necrosis factor alpha-induced apoptosis in cultured mouse hepatocytes Hepatology 36 2002 55 64 (Pubitemid 34700762)
172. P.S. Ribeiro, H. Cortez-Pinto, S. Solá, R.E. Castro, R.M. Ramalho, A. Baptista, M.C. Moura, M.E. Camilo, and C.M. Rodrigues Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients Am. J. Gastroenterol. 99 2004 1708 1717 (Pubitemid 39237497)
173. R.A. Kirkland, J.A. Windelborn, J.M. Kasprzak, and J.L. Franklin A Bax-induced pro-oxidant state is critical for cytochrome c release during programmed neuronal death J. Neurosci. 22 2002 6480 6490 (Pubitemid 35386404)
174. C.C. Tai, and S.T. Ding N-3 polyunsaturated fatty acids regulate lipid metabolism through several inflammation mediators: mechanisms and implications for obesity prevention J. Nutr. Biochem. 21 2010 357 363
175. K. Fukuda, R. Xie, and J.F. Chiu Demonstration of cross-linked cytokeratin polypeptides in transplantable rat hepatoma cells Biochem. Biophys. Res. Commun. 176 1991 441 446
176. V.A. Fadok, D.L. Bratton, A. Konowal, P.W. Freed, J.Y. Westcott, and P.M. Henson Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF J. Clin. Invest. 101 1998 890 898 (Pubitemid 28096086)
177. M. Parola, M. Pinzani, A. Casini, E. Albano, G. Poli, A. Gentilini, P. Gentilini, and M.U. Dianzani Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen a1 (I) gene expression in human liver fat-storing cells Biochem. Biophys. Res. Commun. 194 1993 1044 1050 (Pubitemid 23254985)
178. G. Leonarduzzi, A. Scavazza, F. Biasi, E. Chiarpotto, S. Camandola, S. Vogel, R. Dargel, and G. Poli The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor β1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis FASEB J. 11 1997 851 857 (Pubitemid 27371894)
179. N. Phung, G. Farrell, G. Robertson, and J. George Vitamin E but not glutathione precursors inhibits hepatic fibrosis in experimental NASH exhibiting oxidative stress and mitochondrial abnormalities Hepatology 34 2001 361
180. T. Hasegawa, M. Yoneda, K. Nakamura, I. Makino, and A. Terano Plasma transforming growth factor-β1 level and efficacy of α-tocopherol in patients with non-alcoholic steatohepatitis Aliment. Pharmacol. Ther. 15 2001 1667 1672 (Pubitemid 32912411)
181. N. Ouchi, J.L. Parker, J.J. Lugus, and K. Walsh Adipokines in inflammation and metabolic disease Nat. Rev. Immunol. 11 2011 85 97
182. X. Ding, N.K. Saxena, S. Lin, A. Xu, S. Srinivasan, and F.A. Anania The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology Am. J. Pathol. 166 2005 1655 1669 (Pubitemid 40734389)
183. H. Kanda, S. Tateya, Y. Tamori, K. Kotani, K. Hiasa, R. Kitazawa, S. Kitazawa, H. Miyachi, S. Maeda, K. Egashira, and M. Kasuga MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity J. Clin. Invest. 116 2006 1494 1505
184. C. Pagano, G. Soardo, W. Esposito, F. Fallo, L. Basan, D. Donnini, G. Federspil, L.A. Sechi, and R. Vettor Plasma adiponectin is decreased in nonalcoholic fatty liver disease Eur. J. Endocrinol. 152 2005 113 118 (Pubitemid 40185459)
185. R. Vuppalanchi, S. Marri, D. Kolwankar, R.V. Considine, and N. Chalasani Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study J. Clin. Gastroenterol. 39 2005 237 242 (Pubitemid 40283961)
186. A. Xu, Y. Wang, H. Keshaw, L.Y. Xu, K.S. Lam, and G.J. Cooper The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice J. Clin. Invest. 112 2003 91 100 (Pubitemid 38056380)
187. G. Musso, R. Gambino, M. Durazzo, G. Broli, M. Carello, M. Fagà, G. Pacini, F. De Michieli, L. Rabbione, A. Premoli, M. Cassader, and M. Pagano Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease Hepatology 42 2005 1175 1183 (Pubitemid 43112685)
188. K. Tomita, Y. Oike, T. Teratani, T. Taguchi, M. Noguchi, T. Suzuki, A. Mizutani, H. Yokoyama, R. Irie, H. Sumumoto, A. Takayanagi, K. Miyashita, M. Akao, M. Tabata, G. Tamiya, T. Ohkura, and T. Hibi Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice Hepatology 48 2008 458 473
189. N. Ouchi, S. Kihara, Y. Arita, M. Nishida, A. Matsuyama, Y. Ohmoto, T. Nakamura, S. Yamashita, T. Funahashi, and Y. Matsuzawa Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NFkappaB signaling through a cAMP-dependent pathway Circulation 102 2000 1296 1301
190. A.M. Wolf, D. Wolf, H. Rumpold, B. Enrich, and H. Tilg Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes Biochem. Biophys. Res. Commun. 323 2004 630 635 (Pubitemid 39221142)
191. T. Masaki, S. Chiba, H. Tatsukawa, T. Yasuda, H. Noguchi, M. Seike, and H. Yoshimatsu Adiponectin protects LPS-induced liver injury through modulation of TNFalpha in KK-Ay obese mice Hepatology 40 2004 177 184 (Pubitemid 38868936)
192. A.H. Berg, T.P. Combs, and P.E. Scherer ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism Trends Endocrinol. Metab. 13 2002 84 89 (Pubitemid 36740452)
193. M. Bouskila, U.B. Pajvani, and P.E. Scherer Adiponectin: a relevant player in PPARγ-agonist-mediated improvements in hepatic insulin sensitivity? Int. J. Obes. Relat. Metab. Disord. 29 2005 S17 S23
194. M.B. Chen, A.J. McAinch, S.L. Macaulay, L.A. Castelli, P.E. O'Brien, J.B. Dixon, D. Cameron-Smith, B.E. Kemp, and G.R. Steinberg Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle from obese type 2 diabetics J. Clin. Endocrinol. Metab. 90 2005 3665 3672 (Pubitemid 41014341)
195. J.M. Friedman, and J.L. Halaas Leptin and the regulation of bodyweight in mammals Nature 395 1998 763 770
196. S. Chitturi, G. Farrell, L. Frost, A. Kriketos, R. Lin, C. Fung, C. Liddle, D. Samarasinghe, and J. George Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity Hepatology 36 2002 403 409 (Pubitemid 34810360)
197. I.A. Leclercq, G.C. Farrell, R. Schriemer, and G.R. Robertson Leptin is essential for the hepatic fibrogenic response to chronic liver injury J. Hepatol. 37 2002 206 213 (Pubitemid 34833082)
198. K. Ikejima, Y. Takei, H. Honda, M. Hirose, M. Yoshikawa, Y.J. Zhang, T. Lang, T. Fukuda, S. Yamashina, T. Kitamura, and N. Sato Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat Gastroenterology 122 2002 1399 1400
199. N.K. Saxena, K. Ikeda, D.C. Rockey, S.L. Friedman, and F.A. Anania Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells in lean littermates of ob/ob mice Hepatology 35 2002 762-371
200. M. Tang, J.J. Potter, and E. Mezey Leptin enhances the effect of transforming growth factor β in increasing type I collagen formation Biochem. Biophys. Res. Commun. 297 2002 906 911 (Pubitemid 35230336)
201. A. Uygun, A. Kadayifci, Z. Yesilova, A. Erdil, H. Yaman, M. Saka, M.S. Deveci, S. Bagci, M. Gulsen, N. Karaeren, and K. Dagalp Serum leptin levels in patients with nonalcoholic steatohepatitis Am. J. Gastroenterol. 95 2000 3584 3589
202. Y. Toyoshima, O. Gavrilova, S. Yakar, W. Jou, S. Pack, Z. Asghar, M.B. Wheeler, and D. LeRoith Leptin improves insulin resistance and hyperglycemia in a mouse model of type 2 diabetes Endocrinology 146 2005 4024 4035 (Pubitemid 41175774)
203. G.R. Steinberg, and D.J. Dyck Development of leptin resistance in rat soleus muscle in response to high-fat diets Am. J. Physiol. Endocrinol. Metab. 279 2000 E1374 E1382
204. G.R. Steinberg, M.L. Parolin, G.J. Heigenhauser, and D.J. Dyck Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance Am. J. Physiol. Endocrinol. Metab. 283 2002 E187 E192
205. Y. Lee, X. Yu, F. Gonzales, D.J. Mangelsdorf, M.Y. Wang, C. Richardson, L.A. Witters, and R.H. Unger PPAR-α is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue Proc. Natl. Acad. Sci. U. S. A. 99 2002 11848 11853 (Pubitemid 34994487)
206. J. Licinio, S. Caglayan, M. Ozata, B.O. Yildiz, P.B. de Miranda, F. O'Kirwan, R. Whitby, L. Liang, P. Cohen, S. Bhasin, R.M. Krauss, J.D. Veldhuis, A.J. Wagner, A.M. DePaoli, S.M. McCann, and M.L. Wong Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults Proc. Natl. Acad. Sci. U. S. A. 101 2004 4531 4536 (Pubitemid 38437445)
207. Y.M. Nan, W.J. Wu, N. Fu, B.L. Liang, R.Q. Wang, L.X. Li, S.X. Zhao, J.M. Zhao, and J. Yu Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice Scand. J. Gastroenterol. 15 2009 1 11
208. M.C. Ramirez-Tortosa, C.L. Ramirez-Tortosa, M.D. Mesa, S. Granados, A. Gil, and J.L. Quiles Curcumin ameliorates rabbit steatohepatitis via respiratory chain, oxidative stress, and TNF-α Free Radic. Biol. Med. 47 2009 924 931
209. J.N. Baumgardner, K. Shankar, L. Hennings, E. Albano, T.M. Badger, and M.J. Ronis N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis J. Nutr. 138 2008 1872 1879
210. T. Hasegawa, M. Yoneda, K. Nakamura, I. Makino, and A. Terano Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study Aliment. Pharmacol. Ther. 15 2001 1667-1672
211. J.F. Dufour, C.M. Oneta, J.J. Gonvers, F. Bihl, A. Cerny, J.M. Cereda, J.F. Zala, B. Helbling, M. Steuerwald, A. Zimmermann Swiss Association for the Study of the Liver Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin E in nonalcoholic steatohepatitis Clin. Gastroenterol. Hepatol. 4 2006 1537 1543 (Pubitemid 44880031)
212. S.A. Harrison, S. Torgerson, P. Hayashi, J. Ward, and S. Schenker Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis Am. J. Gastroenterol. 98 2003 2485 2490 (Pubitemid 37448761)
213. A. Dey, A.A. Caro, and A.I. Cederbaum S-adenosyl methionine protects ob/ob mice from CYP2E1-mediated liver injury Am. J. Physiol. Gastrointest. Liver Physiol. 293 2007 G91 G103
214. S.A. Polyzos, J. Kountouras, C. Zavos, and E. Tsiaousi The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease Diabetes Obes. Metab. 12 2010 365 383
215. R. Gutierrez-Juarez, A. Pocai, C. Mulas, H. Ono, S. Bhanot, B.P. Monia, and L. Rossetti Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance J. Clin. Invest. 116 2006 1686 1695
216. K. Hasegawa, S. Wakino, K. Yoshioka, S. Tatematsu, Y. Hara, H. Minakuchi, N. Washida, H. Tokuyama, K. Hayashi, and H. Itoh Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression Biochem. Biophys. Res. Commun. 372 2008 51 56
217. S. Kume, M. Haneda, K. Kanasaki, T. Sugimoto, S. Araki, M. Isono, K. Isshiki, T. Uzu, A. Kashiwagi, and D. Koya Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation Free Radic. Biol. Med. 40 2006 2175 2182 (Pubitemid 43903102)
218. X.Q. Deng, L.L. Chen, and N.X. Li The expression of SIRT1 in nonalcoholic fatty liver disease induced by high-fat diet in rats Liver Int. 27 2007 708 715
219. Y. Yamazaki, I. Usui, Y. Kanatani, Y. Matsuya, K. Tsuneyama, S. Fujisaka, A. Bukhari, H. Suzuki, S. Senda, S. Imanishi, K. Hirata, M. Ishiki, R. Hayashi, M. Urakaze, H. Nemoto, M. Kobayashi, and K. Tobe Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice Am. J. Physiol. Endocrinol. Metab. 297 2009 E1179 E1186
220. G.L. Wang, Y.C. Fu, W.C. Xu, Y.Q. Feng, S.R. Fang, and X.H. Zhou Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1-FOXO1 signaling pathway Biochem. Biophys. Res. Commun. 380 2009 644 649